Nine Chapters Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $358K | Buy |
105,500
+68,100
| +182% | +$231K | 0.79% | 50 |
|
|
2017
Q2 | $92K | Sell |
37,400
-145,600
| -80% | -$358K | 0.87% | 43 |
|
|
2017
Q1 | $415K | Buy |
183,000
+63,300
| +53% | +$144K | 0.56% | 62 |
|
|
2016
Q4 | $254K | Buy |
119,700
+95,400
| +393% | +$202K | 0.43% | 87 |
|
|
2016
Q3 | $81K | Buy |
+24,300
| New | +$81K | 0.57% | 60 |
|
|
2015
Q4 | – | Sell |
-115,500
| Closed | -$581K | – | 924 |
|
|
2015
Q3 | $581K | Buy |
+115,500
| New | +$581K | 0.05% | 521 |
|
|
2014
Q4 | – | Sell |
-22,000
| Closed | -$164K | – | 1372 |
|
|
2014
Q3 | $164K | Buy |
+22,000
| New | +$164K | 0.01% | 879 |
|